Pages

Thursday, March 15, 2018

Pharma Reviews: ChrysCapital may return to Mankind with $400m deal

Mumbai: Indian private equity posterboy ChrysCapital along with its global sponsors have made a surprise late-stage bid to buy a stake of $350-400 million in Mankind ... The fund's partner and pharma industry veteran Sanjiv Kaul has strong ties with Indian pharma entrepreneurs, including the Junejas.
Read more: ChrysCapital may return to Mankind with $400m deal